Serum Electrolyte and Metabolic Changes During Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Patients with Autoimmune Diseases: A Prospective Study in a Single Institution
Hematology/Oncology and Stem Cell Therapy · 2024
DOI: 10.56875/2589-0646.1106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology/Oncology and Stem Cell Therapy, 2024. Verfasst von Brenda J Méndez-Laureano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorios Ruiz, SYNLAB, Puebla, México. Hauptthemen laut MEDLINE: Autoimmune Diseases, Hematopoietic Stem Cell Transplantation, Hyponatremia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background and objectives: A hematopoietic stem cell transplant (HSCT) includes a conditioning regimen which may cause unwanted metabolic changes. We analyzed the changes in electrolytes, glucose, urea, and glomerular filtration rate in patients with multiple sclerosis (MS) who underwent an autologous HSCT employing the “Mexican method”. Patients and methods: Serum and urinary electrolytes, blood glucose, creatinine, uric acid, and estimated glomerular filtration rate (eGFR) were prospectively assessed on days –11, –9, and 0 in a group of 75 patients with MS receiving an autologous HSCT employing the “Mexican method,” which includes high doses of both cyclophosphamide (Cy, 200 mg/kg) and rituximab (1000 mg).
Results
The median age of the patients was 46 years, with a range of 20–65. Baseline data were defined at day –11 of the HSCT. There were significant changes in serum and urinary electrolytes, which diminished substantially after the delivery of high-dose Cy; 12 patients (16%) developed hyponatremia and 2 had hyponatremia-induced seizures, which resulted in hospital admissions. A comparison of baseline blood metabolites with those obtained after the full Cy dosage (day 0) revealed a significant increase in blood glucose and uric acid levels with an associated decrease in serum calcium, sodium, and potassium levels. The salient findings were drug-induced hyponatremia and hyperglycemia.
Conclusion
Significant changes in serum electrolytes, blood glucose, creatinine, uric acid, and estimated glomerular filtration rate (eGFR) were observed in patients given autologous HSCT for MS employing high-dose Cy. Some of these changes may have clinical consequences, mainly those derived from iatrogenic hyponatremia. No evidence of damage to renal function was observed at day 0.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratorios Ruiz, SYNLAB, Puebla, México.
- Universidad Popular Autónoma del Estado de Puebla, Puebla, México.
- Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.
Zitieren
APA
Méndez-Laureano, B. J., Gallardo-Pérez, M. M., Minutti-Zanella, C., & Ruiz-Argüelles, G. J. (2024). Serum Electrolyte and Metabolic Changes During Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Patients with Autoimmune Diseases: A Prospective Study in a Single Institution. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.56875/2589-0646.1106
Vancouver
Méndez-Laureano BJ, Gallardo-Pérez MM, Minutti-Zanella C, Ruiz-Argüelles GJ. Serum Electrolyte and Metabolic Changes During Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Patients with Autoimmune Diseases: A Prospective Study in a Single Institution. Hematology/Oncology and Stem Cell Therapy. 2024. doi:10.56875/2589-0646.1106
BibTeX
@article{MndezLaureano2024,
author = {Méndez-Laureano, Brenda J and Gallardo-Pérez, Moisés M and Minutti-Zanella, Claudia and Ruiz-Argüelles, Guillermo J},
title = {Serum Electrolyte and Metabolic Changes During Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Patients with Autoimmune Diseases: A Prospective Study in a Single Institution},
journal = {Hematology/Oncology and Stem Cell Therapy},
year = {2024},
doi = {10.56875/2589-0646.1106}
}
EUVIMED